Ireland· IE-PA-PA0540/139/001

Adenocor 3 mg/ml solution for injection

A adenosine product containing adenosine, registered in Ireland by Sanofi-Aventis Ireland Limited T/A SANOFI. The same ATC class is registered in 16 of our 19 countries.

ATC C01EB10

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about adenosineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Adenosine is registered in 16 of 19 countries.

Countries holding a registration under ATC C01EB10 (adenosine), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
8 of them publish a price we can compare per daily dose

Search adenosine products by name

Adenosine · ATC C01EB10

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)

Active substance: Adenosine
Manufacturer: Sanofi-Aventis Ireland Limited T/A SANOFI
Country: Ireland (IE)
ATC code: C01EB10
ATC class: Adenosine
Defined daily dose: 15 mg, P
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA0540/139/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

181 interactions on record for adenosine.

Graded by severity as the source publishes them — 38 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check adenosine against other medicines How interaction checks work

Adenosine · interactions on record

181 records

38 severe
90 moderate
1 minor
52 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
PapaverinC04AX38severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Adenosine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All adenosine products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

Austria · Adenosin Baxter, Adenosin Hikma
Belgium · Adenocor, Adenosine Fresenius Kabi
Cyprus · Caden
Czechia · Adenocor
Germany · Adenoscan, Adenosin Altamedics
Denmark · Adenocor, Adenosin Fresenius Kabi
Estonia · Adenosin Life Medical
Spain · Adenocor, Adenoscan
Finland · Adenosin Life Medical, Adenosin Macure
France · Adenoscan, Adenosine Hikma
United Kingdom (Northern Ireland) · Adenocor, Adenoscan
Greece · Adenorythm
Hungary · Adenocor
Italy · Adenoscan, Adenosina Hikma
Lithuania · Adenosine Life Medical
Luxembourg · Adenocor
Netherlands · Adenocor, Adenosine Fresenius Kabi
Norway · Adenosin Life Medical, Adenosin Macure
Poland · Adenocor
Portugal · Adenoscan, Adenosina Baxter
Sweden · Adenosin Life Medical, Adenosin Macure
Slovakia · Adenocor

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/20009bca-a3fa-4364-8a95-f5ddd2d47278
GET /v1/drugs/20009bca-a3fa-4364-8a95-f5ddd2d47278?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "C01EB",
    "C01EB10"
  ],
  "strength": null,
  "pa_number": "PA0540/139/001",
  "substances": [
    "Adenosine"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "16/06/1994",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about adenosine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console